Not all polyriboinosinic-polyribocytidylic acids (Poly I:C) are equivalent for inducing maturation of dendritic cells: implication for alpha-type-1 polarized DCs
- PMID: 19342970
- DOI: 10.1097/CJI.0b013e31819d29bf
Not all polyriboinosinic-polyribocytidylic acids (Poly I:C) are equivalent for inducing maturation of dendritic cells: implication for alpha-type-1 polarized DCs
Abstract
This study compares the behavior of 2 commercially available polyriboinosinic-polyribocytidylic acids (poly I:C1 and poly I:C2) and the structural analog poly I:C12U in regard to dendritic cell (DC) maturation. When the Toll-like receptor 3 (TLR3) agonists are tested in combination with interferon-alpha, tumor necrosis factor-alpha, interleukin (IL)-1beta, and interferon-gamma (the so-called alpha-type-1 DC), the 3 different cocktails generate phenotypically mature DCs, but with different functional properties. Higher migratory capacity is observed with poly I:C1, the only poly I:C allowing spontaneous release of IL-12p70 by DCs. However, upon CD40 triggering, cocktails containing poly I:C2 or poly I:C12U allow a far higher production of IL-12p70 compared with those containing poly I:C1. Using a TLR signaling pathway reverse transcription profiler polymerase chain reaction to analyze changes in gene expression after treatment of DCs with the agonists alone, we show that 39% of the 84 tested genes are differentially regulated between the 3 conditions. Poly I:C12U induces far fewer regulated genes than the 2 other poly I:Cs. These different behaviors could be due to alternative ways of sensing double-stranded RNA, which do not rely solely on TLR3 but also on other types of receptors, depending on the size of poly I:Cs. As the 2 poly I:Cs tested here have very different molecular weights, this could partly explain the observed differences. In conclusion, neither the poly I:Cs nor their structural analog poly I:C12U have an equivalent behavior. This should be taken into an account not only when they are used in cocktails for DC maturation but also when analyzing signaling pathways with synthetic double-stranded RNA analogs.
Similar articles
-
Dendritic cell maturation with poly(I:C)-based versus PGE2-based cytokine combinations results in differential functional characteristics relevant to clinical application.J Immunother. 2008 Jun;31(5):506-19. doi: 10.1097/CJI.0b013e318177d9e5. J Immunother. 2008. PMID: 18463533
-
Maturation of murine bone marrow-derived dendritic cells with poly(I:C) produces altered TLR-9 expression and response to CpG DNA.Immunol Lett. 2006 Nov 15;107(2):155-62. doi: 10.1016/j.imlet.2006.09.001. Epub 2006 Sep 22. Immunol Lett. 2006. PMID: 17011046
-
TLR3: interferon induction by double-stranded RNA including poly(I:C).Adv Drug Deliv Rev. 2008 Apr 29;60(7):805-12. doi: 10.1016/j.addr.2007.11.005. Epub 2008 Jan 2. Adv Drug Deliv Rev. 2008. PMID: 18262679 Review.
-
Poly(I:C) used for human dendritic cell maturation preserves their ability to secondarily secrete bioactive IL-12.Int Immunol. 2004 May;16(5):767-73. doi: 10.1093/intimm/dxh077. Epub 2004 Mar 29. Int Immunol. 2004. PMID: 15096480
-
Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant.Adv Drug Deliv Rev. 2013 Oct;65(10):1386-99. doi: 10.1016/j.addr.2013.05.013. Epub 2013 Jun 7. Adv Drug Deliv Rev. 2013. PMID: 23751781 Review.
Cited by
-
Discordant biological and toxicological species responses to TLR3 activation.Am J Pathol. 2014 Apr;184(4):1062-1072. doi: 10.1016/j.ajpath.2013.12.006. Epub 2014 Jan 30. Am J Pathol. 2014. PMID: 24486326 Free PMC article. Clinical Trial.
-
Exploiting poly(I:C) to induce cancer cell apoptosis.Cancer Biol Ther. 2017 Oct 3;18(10):747-756. doi: 10.1080/15384047.2017.1373220. Epub 2017 Sep 7. Cancer Biol Ther. 2017. PMID: 28881163 Free PMC article. Review.
-
PolyICLC Exerts Pro- and Anti-HIV Effects on the DC-T Cell Milieu In Vitro and In Vivo.PLoS One. 2016 Sep 7;11(9):e0161730. doi: 10.1371/journal.pone.0161730. eCollection 2016. PLoS One. 2016. PMID: 27603520 Free PMC article.
-
Immunomodulatory effects of dsRNA and its potential as vaccine adjuvant.J Biomed Biotechnol. 2010;2010:690438. doi: 10.1155/2010/690438. Epub 2010 Jul 5. J Biomed Biotechnol. 2010. PMID: 20671921 Free PMC article. Review.
-
Intranasal administration of dsRNA analog poly(I:C) induces interferon-α receptor-dependent accumulation of antigen experienced T cells in the airways.PLoS One. 2012;7(12):e51351. doi: 10.1371/journal.pone.0051351. Epub 2012 Dec 7. PLoS One. 2012. PMID: 23236482 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous